{"nct_id":"NCT04524611","title":"Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2020-09-30","start_date_type":"ACTUAL","primary_completion_date":"2028-02","primary_completion_date_type":"ESTIMATED","completion_date":"2028-02","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["ABBV"]}